Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Investigation of tumor hypoxia using a two-enzyme system for in vitro generation of oxygen deficiency.

Askoxylakis V, Millonig G, Wirkner U, Schwager C, Rana S, Altmann A, Haberkorn U, Debus J, Mueller S, Huber PE.

Radiat Oncol. 2011 Apr 10;6:35. doi: 10.1186/1748-717X-6-35.

2.

The GOX/CAT system: a novel enzymatic method to independently control hydrogen peroxide and hypoxia in cell culture.

Mueller S, Millonig G, Waite GN.

Adv Med Sci. 2009;54(2):121-35. doi: 10.2478/v10039-009-0042-3.

PMID:
20022860
3.
4.

Enzyme-immobilized hydrogels to create hypoxia for in vitro cancer cell culture.

Dawes CS, Konig H, Lin CC.

J Biotechnol. 2017 Apr 20;248:25-34. doi: 10.1016/j.jbiotec.2017.03.007. Epub 2017 Mar 8.

5.

Expression and prognostic significance of a panel of tissue hypoxia markers in head-and-neck squamous cell carcinomas.

Le QT, Kong C, Lavori PW, O'byrne K, Erler JT, Huang X, Chen Y, Cao H, Tibshirani R, Denko N, Giaccia AJ, Koong AC.

Int J Radiat Oncol Biol Phys. 2007 Sep 1;69(1):167-75.

PMID:
17707270
6.

Three-dimensional culture promotes reconstitution of the tumor-specific hypoxic microenvironment under TGFβ stimulation.

Marushima H, Shibata S, Asakura T, Matsuura T, Maehashi H, Ishii Y, Eda H, Aoki K, Iida Y, Morikawa T, Ohkawa K.

Int J Oncol. 2011 Nov;39(5):1327-36. doi: 10.3892/ijo.2011.1142. Epub 2011 Jul 22.

PMID:
21785823
7.

Tumor hypoxia at the micro-regional level: clinical relevance and predictive value of exogenous and endogenous hypoxic cell markers.

Bussink J, Kaanders JH, van der Kogel AJ.

Radiother Oncol. 2003 Apr;67(1):3-15. Review.

PMID:
12758235
8.

Silencing of GLUT-1 inhibits sensitization of oral cancer cells to cisplatin during hypoxia.

Shimanishi M, Ogi K, Sogabe Y, Kaneko T, Dehari H, Miyazaki A, Hiratsuka H.

J Oral Pathol Med. 2013 May;42(5):382-8. doi: 10.1111/jop.12028. Epub 2012 Dec 10.

PMID:
23227892
9.
10.

Identifying pH independent hypoxia induced genes in human squamous cell carcinomas in vitro.

Sørensen BS, Toustrup K, Horsman MR, Overgaard J, Alsner J.

Acta Oncol. 2010 Oct;49(7):895-905. doi: 10.3109/02841861003614343.

PMID:
20429727
12.

The usefulness of three-dimensional cell culture in induction of cancer stem cells from esophageal squamous cell carcinoma cell lines.

Fujiwara D, Kato K, Nohara S, Iwanuma Y, Kajiyama Y.

Biochem Biophys Res Commun. 2013 May 17;434(4):773-8. doi: 10.1016/j.bbrc.2013.04.008. Epub 2013 Apr 18.

PMID:
23602898
13.

Comparison of cisplatin sensitivity and the 18F fluoro-2-deoxy 2 glucose uptake with proliferation parameters and gene expression in squamous cell carcinoma cell lines of the head and neck.

Henriksson E, Kjellén E, Baldetorp B, Bendahl PO, Borg A, Brun E, Mertens F, Ohlsson T, Rennstam K, Wennerberg J, Wahlberg P.

J Exp Clin Cancer Res. 2009 Feb 13;28:17. doi: 10.1186/1756-9966-28-17.

14.

Activation of AKT by hypoxia: a potential target for hypoxic tumors of the head and neck.

Stegeman H, Kaanders JH, Wheeler DL, van der Kogel AJ, Verheijen MM, Waaijer SJ, Iida M, Grénman R, Span PN, Bussink J.

BMC Cancer. 2012 Oct 10;12:463. doi: 10.1186/1471-2407-12-463.

15.

Relation of erythropoietin and erythropoietin receptor expression to hypoxia and anemia in head and neck squamous cell carcinoma.

Winter SC, Shah KA, Campo L, Turley H, Leek R, Corbridge RJ, Cox GJ, Harris AL.

Clin Cancer Res. 2005 Nov 1;11(21):7614-20.

16.

Induction of plasminogen activator inhibitor type-1 (PAI-1) by hypoxia and irradiation in human head and neck carcinoma cell lines.

Schilling D, Bayer C, Geurts-Moespot A, Sweep FC, Pruschy M, Mengele K, Sprague LD, Molls M.

BMC Cancer. 2007 Jul 30;7:143.

17.

Galectin-1: a link between tumor hypoxia and tumor immune privilege.

Le QT, Shi G, Cao H, Nelson DW, Wang Y, Chen EY, Zhao S, Kong C, Richardson D, O'Byrne KJ, Giaccia AJ, Koong AC.

J Clin Oncol. 2005 Dec 10;23(35):8932-41. Epub 2005 Oct 11.

PMID:
16219933
18.

High stromal carbonic anhydrase IX expression is associated with decreased survival in P16-negative head-and-neck tumors.

Brockton N, Dort J, Lau H, Hao D, Brar S, Klimowicz A, Petrillo S, Diaz R, Doll C, Magliocco A.

Int J Radiat Oncol Biol Phys. 2011 May 1;80(1):249-57. doi: 10.1016/j.ijrobp.2010.11.059.

PMID:
21300470
19.

Radiosensitivity and effect of hypoxia in HPV positive head and neck cancer cells.

Sørensen BS, Busk M, Olthof N, Speel EJ, Horsman MR, Alsner J, Overgaard J.

Radiother Oncol. 2013 Sep;108(3):500-5. doi: 10.1016/j.radonc.2013.06.011. Epub 2013 Aug 13.

PMID:
23953409
20.

Increase in gene dosage is a mechanism of HIF-1alpha constitutive expression in head and neck squamous cell carcinomas.

Secades P, Rodrigo JP, Hermsen M, Alvarez C, Suarez C, Chiara MD.

Genes Chromosomes Cancer. 2009 May;48(5):441-54. doi: 10.1002/gcc.20652.

PMID:
19235921

Supplemental Content

Support Center